
Management of Primary-Open Angle Glaucoma *ACPE-Accredited*
04/04/23 • 58 min
On this episode, we review the pharmacotherapy options available for managing primary-open angle glaucoma. We discuss prostaglandin analogs, beta-blockers, alpha-2 agonists, carbonic anhydrase inhibitors, cholinergics, rho kinase inhibitor, and more. We also briefly review angle-closure glaucoma to finish the episode.
Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website:
If you’re not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast.
Thanks for listening!
We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
- Mike - [email protected]
- Cole - [email protected]
- AJ - [email protected]
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
On this episode, we review the pharmacotherapy options available for managing primary-open angle glaucoma. We discuss prostaglandin analogs, beta-blockers, alpha-2 agonists, carbonic anhydrase inhibitors, cholinergics, rho kinase inhibitor, and more. We also briefly review angle-closure glaucoma to finish the episode.
Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website:
If you’re not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast.
Thanks for listening!
We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
- Mike - [email protected]
- Cole - [email protected]
- AJ - [email protected]
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Previous Episode

The Psychedelic Renaissance and its Impact on Behavioral Health
On this episode, we are joined by long-time friend of the show, Amelia Furbish, PharmD, PhD candidate, to discuss the emergence of psychedelics and their potential role in managing behavioral health conditions. If you are interested in learning more about medicinal psychedelics, we encourge you to check out and consider becoming a member of the Psychedelic Pharmacists Association (see the website below):
https://psychedelicpharmacist.org/
Thanks for listening!
We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
- Mike - [email protected]
- Cole - [email protected]
- AJ - [email protected]
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Next Episode

Mixing Laughter and Medicine with the Glaucomfleckens
On this episode, we are joined by Dr. Will Flanary (AKA Dr. Glaucomflecken) and Kristin Flanary (AKA Lady Glaucomflecken). Dr. Flanary is a practicing ophthalmology who also creates hilarious skits incorporating a wide range of characters who worked at a fictional hospital called "Glaucomflecken General." As Dr. Glaucomflecken, he has collaborated with the US Surgeon General, given the 2022 Yale Medical School commencement address, and amassed a fan following of more than 4 million. Kristin Flanary was formally trained in cognitive neuroscience and social psychology and now works in marketing and communications. Together, they recently launched their hit podcast, Knock Knock, HI!. Check out their content on their various platforms below:
Website: https://glaucomflecken.com/podcast/
TikTok: @DrGlaucomflecken
YouTube: Dr. Glauckenflecken
Twitter: @DGlaucomflecken
Thanks for listening!
We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
- Mike - [email protected]
- Cole - [email protected]
- AJ - [email protected]
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/corconsult-rx-evidence-based-medicine-and-pharmacy-39843/management-of-primary-open-angle-glaucoma-acpe-accredited-29126484"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to management of primary-open angle glaucoma *acpe-accredited* on goodpods" style="width: 225px" /> </a>
Copy